Cigdem Yasar Selected Research

Steroids

3/2024	Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies.
1/2022	Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cigdem Yasar Research Topics

Disease

4	Uveitis 05/2024 - 01/2022
2	Inflammation (Inflammations) 01/2023 - 11/2022
1	Scleritis (Episcleritis) 03/2024
1	Corneal Ulcer 03/2024
1	Orbital Pseudotumor 03/2024
1	Panuveitis 03/2024
1	Retinal Vasculitis 03/2024
1	Macular Degeneration (Age-Related Maculopathy) 11/2023
1	Meningitis 01/2023
1	Neurologic Manifestations (Neurological Manifestations) 01/2023
1	Retinal Perforations 01/2023
1	Weight Gain 01/2022
1	Photophobia (Light Sensitivity) 01/2015
1	Edema (Dropsy) 01/2015
1	Eye Pain 01/2015
1	Anterior Uveitis 01/2015

Drug/Important Bio-Agent (IBA)

2	Fluorescein (Funduscein)FDA LinkGeneric 05/2024 - 11/2022
2	SteroidsIBA 03/2024 - 01/2022
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 03/2024
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 11/2023
1	montelukast (Singulair)FDA Link 11/2023
1	Prednisone (Sone)FDA LinkGeneric 01/2023
1	Infliximab (Remicade)FDA Link 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 01/2023
1	tocilizumab (atlizumab)FDA Link 12/2022
1	Methylprednisolone FDA LinkGeneric 01/2022
1	Methylprednisolone Hemisuccinate (A-MethaPred)FDA LinkGeneric 01/2022
1	alexandriteIBA 01/2015

Therapy/Procedure

2	Therapeutics 01/2023 - 12/2022
1	Immunomodulation 03/2024
1	Vitrectomy 01/2023
1	Duration of Therapy 01/2022
1	Lasers (Laser) 01/2015
1	Hair Removal (Depilation) 01/2015